About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNANCT05755607

A Multicenter Prospective Randomized Controlled Study of RPD Versus LPD

laparoscopic pancreaticoduodenectomy(LPD) and Robot Pancreaticoduodenectomy (RPD), as two minimally invasive methods of pancreaticoduodenectomy(PD), have obvious advantages over traditional open pancr...

Lead sponsor: The First Affiliated Hospital of University of South China•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Guodong Chen, PhD

CONTACT

(+86)15211450345 Chenguodong@usc.edu.cn

Danjun Chen, PhD

CONTACT

(+86)13789353900 nhfykyb@163.com

Sponsors

Lead Sponsor

The First Affiliated Hospital of University of South China

In this trial, subjects proposed for PD were randomly divided into two groups, LPD and RPD, according to inclusion and exclusion criteria. Patients in both groups were operated and received perioperative management under the same surgical team and were operated according to the standard PD surgical approach. Subsequently, perioperative clinical data and long-term prognostic data of subjects in both groups will be collected and statistically analyzed to explore a better surgical approach.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Over 18 years old
•Preoperative imaging suggested the presence of space occupying in the head of the pancreas, ampullary abdomen, and distal common bile duct tumor lesions to be treated with Pancreaticoduodenectomy
•No distant transfer
•No significant vascular invasion was received

Exclusion Criteria

•With tumors of other organs
•Patients unable to tolerate anesthesia and operation due to serious abnormalities in functions of heart, lung and other important organs
•Patients found intraoperative peripheral organ metastasis combined with excision of other organs or found intraoperative radical excision could not be performed and underwent palliative drainage surgery or end the surgery
•Preoperative adjuvant therapy was given

Related studies

Determining Minimal Residual Disease Using ctDNA Deep Sequencing

NCT07660627 · Esophageal Adenocarcinoma, Gastric Cancer, and more

Indocyanine Green-Guided Versus Standard Laparoscopic Distal Pancreatectomy for Pancreatic Body and Tail Lesions

NCT07656571 · Pancreatic Neoplasms, Pancreatic Cancer

A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

NCT07651358 · Stage I Pancreatic Cancer AJCC v8, Stage II Pancreatic Cancer AJCC v8, and more

RECRUITINGPhase 1

A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

NCT07300150 · Colorectal Cancer, Pancreatic Cancer, and more

Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer

NCT06160323 · Pancreatic Cancer Non-resectable, Tumor Pancreas, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 6, 2023Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment200

Start dateJun 2023

Last updatedMar 6, 2023

Condition

Pancreatic Cancer Common Bile Duct Diseases Periampullary Carcinoma

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 6, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions